The following table highlights currently available prescription opioids in Canada, including formulations and strengths. Any of the coverage notes are specific to the province of Alberta.
Click icon in bottom right hand corner to view full screen.
Credit: Table composed by Kevin Thai and Humirah Sultani
What a brilliant initiative from CAPhO's (Canadian Association of Pharmacy in Oncology) Education Committee! A virtual conference on oncology pharmacy fundamentals - fully accredited.
Are you new to oncology or a general pharmacy practitioner with cancer patients in your practice?
Are you looking for core education on common oncology diseases and cancer treatment toxicities?
The following table highlights currently available prescription opioids in Canada, including formulations and strengths. Any of the coverage notes are specific to the province of Alberta.
Click on the download icon (upper right hand corner) or the title below to view table in full screen mode.
Opioids Available in Canada:
Medications past best before date may lose potency, but how soon? | Canadian Healthcare Network - Pharmacists:
Excerpt of key points from the article:
McMaster University > Michael G. DeGroote National Pain Centre > Canadian Guideline for Opioid Use for Pain — Appendix B-12: Opioid Tapering:
"Rate of the Taper
The rate of the taper can vary from 10% of the total daily dose every day, to 10% of the total daily dose every 1–2 weeks.
Via Pallium Canada, who have been producing a great series of videos helping to bridge the gap with respect to some of the misconceptions surrounding palliative care.
The much referred to NEJM Temel article highlighted the positive impact of early palliative care in terms of symptom management and even extending life. The Pallium group summarize this nicely:
"Recommendations: On the basis of the paucity of high-quality, consistent evidence, there are no agents recommended for the prevention of CIPN. With regard to the treatment of existing CIPN, the best available data support a moderate recommendation for treatment with duloxetine. Although the CIPN trials are inconclusive regarding tricyclic antidepressants (such as nortriptyline), gabapentin, and a compounded topical gel containing baclofen, amitriptyline HCL, and ketamine, these agents may be offered on the basis of data supporting their utility in other neuropathic pain conditions given the limited other CIPN treatment options. Further research on these agents is warranted."Link to the guidelines, summary, slide deck, etc. at ASCO website: click here
"Video maps growth in doctors, nurses and healthcare professionals using Twitter since its launch in 2006 to 2014. Data sourced using Creation Pinpoint, the world's largest research tool for learning from healthcare professionals in public social media."
 |
| Sodium valproate is a common mood stabilizer (Photo credit: Wikipedia) |
 |
| A mirror box used for treating phantom limbs, developed by V.S. Ramachandran. (Photo credit: Wikipedia) |
The WPCA - Global Atlas of Palliative Care:
"Published jointly by the World Health Organization and the Worldwide Palliative Care Alliance, the Atlas is the first document to map the need for and availability of palliative care globally.
Using maps, graphs and case studies, and drawing on a wealth of resources, the Atlas addresses the following questions:
CancerThrombosis.org :: Treatment and Secondary Prevention:
"The American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Key recommendations for secondary prevention of recurrent VTE19"
Personalized Cancer Treament, From Just a Blood Sample - The Crux | DiscoverMagazine.com:
"A technique being developed by San Diego–based Epic Sciences can determine whether a cancer patient is an appropriate candidate for a drug, and even whether the drug is losing its efficacy.
In research presented last month at the Personalized Medicine World Conference in Palo Alto, CA, Epic described how their technology can be used to reliably pick out rare cells from a blood sample. In the case of cancer, these rare, circulating tumor cells could one day tell an oncologist not only whether a patient’s cancer has returned, but also whether it’s growing resistant to the current treatment regimen—something only expensive scans and invasive biopsies can do with any accuracy today."
Read the full article here
 |
| English: Chemical structure of zolpidem (Photo credit: Wikipedia) |
Could electronically controlled drugs reduce side effects? | Cutting Edge - CNET News:
In the realm of oncology this could have especially dramatic ramifications.
Excerpt:
"Reporting in the journal ACS Nano, researchers led by Dr. Xinyan Tracy Cui at the University of Pittsburgh say their new approach allows them to electronically control the release of very specific amounts of drugs to certain parts of the body. To do this, they incorporated extremely thin nanosheets of graphene oxide that were loaded with the anti-inflammatory drug dexamethasone into a polymer scaffold that conducts electricity. By zapping the nanosheets with an electric current, they were able to release the drug -- using the thickness of the sheets to control how much drug was being carried, and the number and magnitude of zaps to control how much of the drug was released."
Full article: click here
Posts
All Comments
© Blogger templates Newspaper III by Ourblogtemplates.com 2008
Back to TOP
